InvestorsHub Logo
Followers 47
Posts 3929
Boards Moderated 0
Alias Born 03/04/2012

Re: None

Friday, 02/21/2020 1:02:40 AM

Friday, February 21, 2020 1:02:40 AM

Post# of 403020
I was surprised the SP didn't rise higher when IPIX announced that Locust Walk was "further engaged," to lead negotiations for B-OM, given LW's good track record. Its all about "show me the money" and the OM and UC/CD indications are billion dollar markets waiting to be tapped by Brilacidin.

Dr. Bert didn't get a deal done, and as a skin doctor (dermatology), his value to the company decreased when the P drug was scrubbed. As CMO he got no B-OM deal inked, and I suspect Leo asked for his resignation knowing Locust Walk could fill his negotiator shoes.

IPIX has valuable assets ready to be unlocked, and AlfaSigma has rights of first refusal for one of them.

With a projected 40+ Billion dollar market for UC and Crohn's, and a pill that targets the colon with Brilacidin as payload, we could see some fireworks sooner than later.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News